For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
References
1. BPACnz. Polypharmacy POEM. May 2006.
2. 2023 American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2023;71(7):2052–81.
3. Lunghi C, Domenicali M, Vertullo S, et al. Adopting STOPP/START criteria version 3 in clinical practice: A Q&A guide for healthcare professionals. Drug Saf 2024;47(11):1061–74.
4. Carollo M, Crisafulli S, Vitturi G, et al. Clinical impact of medication review and deprescribing in older inpatients: A systematic review and meta-analysis. J Am Geriatr Soc 2024;72(10):3219–38.
5. Inglis JM, Caughey G, Thynne T, et al. Inappropriate prescribing and association with readmission or mortality in hospitalised older adults with frailty: a systematic review and meta-analysis. BMC Geriatr 2024;24(1):718.
6. Liu L, Harrison J. Development of explicit criteria identifying potentially inappropriate polypharmacy in older adults in New Zealand primary care: a mixed-methods study. J Prim Health Care 2023;15(1):38–47.
7. Stats NZ. New Zealand cohort life tablets: March 2023 update.
8. Herr M, Arvieu JJ, Ankri J, Robine JM. What is the duration of life expectancy in the state of frailty? Estimates in the SIPAF study. Eur J Ageing 2017;15(2):165–73.
9. Mancia G, Kreutz R, Brunström M, et al. 2023 ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension. J Hypertens 2023;41(12):1874–2071.
10. Takramah WK, Asem L. The efficacy of pharmacological interventions to improve cognitive and behavior symptoms in people with dementia: A systematic review and meta-analysis. Health Sci Rep 2022;5(6):e913.
11. Sheikh M, Ammar M. Efficacy of 5 and 10 mg donepezil in improving cognitive function in patients with dementia: a systematic review and meta-analysis. Front Neurosci 2024;18:1398952.
12. d'Angremont E, Begemann MJH, van Laar T, Sommer IEC. Cholinesterase inhibitors for treatment of psychotic symptoms in Alzheimer disease and Parkinson disease: A meta-analysis. JAMA Neurol 2023;80(8):813–23.
13. Zhang X, Lian S, Zhang Y, Zhao Q. Efficacy and safety of donepezil for mild cognitive impairment: A systematic review and meta-analysis. Clin Neurol Neurosurg 2022;213:107134.
![New Zealand Doctor Rata Aotearoa editor Barbara Fountain, RNZCGP president elect and Tauranga-based specialist GP Luke Bradford, Ministry of Health clinical chief advisor rural health Helen MacGregor, and Health New Zealand Te Whatu Ora clinical director primary and community care Sarah Clarke [Image: NZD]](/sites/default/files/styles/thumbnail_cropped_100/public/2025-05/1.%20Barbara%20Fountain%2C%20Luke%20Bradford%2C%20Helen%20MacGregor%20and%20Sarah%20Clarke.jpg?itok=091NETXI)
![Ngāti Porou Oranga specialist GP Elina Pekansaari and Te Nikau Hospital specialist in general practice and rural hospital medicine David Short [Image: NZD]](/sites/default/files/styles/thumbnail_cropped_100/public/2025-05/2.%20Elina%20Pekansaari%20and%20David%20Short.jpg?itok=h5XfSBVM)
![Locum specialist GP Margriet Dijkstra and OmniHealth regional operations manager (southern) Patricia Morais-Ross [Image: NZD]](/sites/default/files/styles/thumbnail_cropped_100/public/2025-05/3.%20Margriet%20Dijkstra%20and%20Patricia%20Morais-Ross.jpg?itok=jkrtRfJC)
![Golden Bay dairy farmer and dairy industry health and safety doctoral student Deborah Rhodes, and Golden Bay Community Health specialist GP Rachael Cowie [Image: NZD]](/sites/default/files/styles/thumbnail_cropped_100/public/2025-05/4.%20Deborah%20Rhodes%20and%20Rachael%20Cowie.jpg?itok=oM0_GcJc)
![Hauora Taiwhenua clinical director rural health Jeremy Webber, Australian College of Rural and Remote Medicine president Rod Martin and Observa Care director of business operations Deborah Martin, the wife of Dr Martin [Image: NZD]](/sites/default/files/styles/thumbnail_cropped_100/public/2025-05/5.%20Jeremy%20Webber%2C%20Rod%20Martin%20and%20Deborah%20Martin%2C%20the%20wife%20of%20Dr%20Martin.jpg?itok=P_aGmX_H)
![Spark Health chief executive John Macaskill-Smith and client director Bryan Bunz [Image: NZD]](/sites/default/files/styles/thumbnail_cropped_100/public/2025-05/6.%20John%20Macaskill-Smith%20and%20Bryan%20Bunz.jpg?itok=5yJvVZ0I)
![Associate dean (rural) Kyle Eggleton, third-year medical student Roselle Winter, and second-year pharmacy student Alina Khanal, all from the University of Auckland [Image: NZD]](/sites/default/files/styles/thumbnail_cropped_100/public/2025-05/7.%20Kyle%20Eggleton%2C%20Roselle%20Winter%20and%20Alina%20Khanal.jpg?itok=RQLd3TEs)
![Health New Zealand Te Whatu Ora clinical editor and specialist in general practice and rural hospital medicine Anu Shinnamon, and Whakarongorau chief clinical officer Ruth Large [Image: NZD]](/sites/default/files/styles/thumbnail_cropped_100/public/2025-05/8.%20Anu%20Shinnamon%20and%20Ruth%20Large.jpg?itok=i5TMswY9)
![Te Kahu Hauora Practice specialist GP Jane Laver and Ngāti Kahungunu ki Tāmaki-nui-a-Rua chief operations manager Tania Chamberlain [Image: NZD]](/sites/default/files/styles/thumbnail_cropped_100/public/2025-05/9.%20Jane%20Laver%20and%20Tania%20Chamberlain.jpg?itok=jtMklaCZ)